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Abstract We tested the hypothesis that myocardial con-
tractile protein phosphorylation and the Ca
2? sensitivity of
force production are dysregulated in a porcine model of
pacing-induced heart failure (HF). The level of protein
kinase A (PKA)-dependent cardiac troponin I (TnI) phos-
phorylation was lower in the myocardium surrounding the
pacing electrode (pacing site) of the failing left ventricle
(LV) than in the controls. Immunohistochemical assays of
the LV pacing site pointed to isolated clusters of cardio-
myocytes exhibiting a reduced level of phosphorylated
TnI. Flow cytometry on isolated and permeabilized
cardiomyocytes revealed a signiﬁcantly larger cell-to-cell
variation in the level of TnI phosphorylation of the LV
pacing site than in the opposite region in HF or in either
region in the controls: the interquartile range (IQR) on the
distribution histogram of relative TnI phosphorylation was
wider at the pacing site (IQR = 0.53) than that at the
remote site of HF (IQR = 0.42; P = 0.0047) or that of the
free wall of the control animals (IQR = 0.36; P = 0.0093).
Additionally, the Ca
2? sensitivities of isometric force pro-
duction were higher and appeared to be more variable in
single permeabilized cardiomyocytes from the HF pacing
site than in the healthy myocardium.In conclusion, the level
of PKA-dependent TnI phosphorylation and the Ca
2? sen-
sitivity of force production exhibited a high cell-to-cell
variability at the LV pacing site, possibly explaining the
abnormalities of the regional myocardial contractile func-
tion in a porcine model of pacing-induced HF.
Keywords Cardiac function   Pacing-induced heart
failure   b-adrenergic signaling   Dilated cardiomyopathy  
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Introduction
Changes in the expression and post-translational modiﬁ-
cations of myocardial proteins occur in the molecular
background of myocardial remodeling during the devel-
opment of chronic heart failure (HF). These alterations
affect the myocardial structure and are responsible for
disturbances in cellular functions ranging from intracellular
signaling through cardiomyocyte contractility to metabo-
lism. In this context, a number of studies have implicated
the involvement of myoﬁlamentary proteins in the pro-
gressive decay of the myocardial function [12, 30, 33, 42].
In the failing human heart, a downgraded b-adrenergic
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DOI 10.1007/s00395-012-0244-xresponsiveness was found to be associated with an
increased Ca
2? sensitivity of force production through a
diminished level of protein kinase A (PKA)-mediated tro-
ponin I (TnI) and myosin-binding protein-C (MyBP-C)
phosphorylation [6, 27, 41, 43–45], although these rela-
tionships were not fully conﬁrmed in all models of HF
[4, 5, 28, 37]. Some of the discrepancies arise from the
complexity of the human pathology, the difﬁculty of ﬁnding
reliable human control materials, and possible species-
dependent differences between signaling pathways in large
and small mammals [26, 35]. It follows that investigations in
large animal models of HF are of great importance, as they
will possibly elucidate HF-speciﬁc protein alterations with
direct relevance for the human pathology.
A well-established large animal model of HF, induced by
continuous cardiac pacing at a frequency three- to fourfold
higher than the spontaneous heart rate, is mostly applied to
dogs, pigs, sheep, and monkeys [15, 34]. One characteristic
of this model is the presence of regional differences in
functional and molecular remodeling. For example, in a
canine tachy-pacing HF model, regional differences were
noted in the extent of action potential prolongation and
intracellular Ca
2? homeostasis abnormalities [1]. More-
over, cardiac resynchronization therapy in these hearts
furnished non-uniform responses [2]. In a porcine model of
HF, sustained pacing-induced dyssynchronous left ventric-
ular (LV) activation caused more pronounced decreases in
LV systolic thickening and circumferential shortening in
the anterior/anterolateral region (pacing site) as compared
with the inferoseptal region (opposite site) (to *7 vs.
*31% and to *-5v s . *-7%, respectively), which were
unrelated to a uniform increase in glucose uptake in the
corresponding regions [further parameters of in vivo
hemodynamic alterations of this model have been detailed
in a previous study [23] (p. H2750, Table 1)]. However,
these changes did correlate with an asymmetrical myocar-
dial expression of natriuretic peptides [10].
In the present study, we set out to investigate a hypo-
thetical relationship between PKA-dependent myoﬁlament
hypophosphorylation and the contractile dysfunction in a
porcine model of pacing-induced HF. With a view to
analyzing PKA-dependent TnI phosphorylation at the tis-
sue and cellular levels, we performed biochemical studies
(back-phosphorylation) in tissue homogenates, immuno-
histochemical studies in LV tissue slices, and ﬂow cyto-
metric assays in a large number of permeabilized
cardiomyocytes isolated from paced and non-paced regions
of failing LVs. To assess functional correlates, we mea-
sured the Ca
2? sensitivity of isometric force production
(pCa50) and additional mechanical parameters of isolated
cardiomyocytes of failing and healthy hearts.
Our data revealed disparate myocardial tissue charac-
teristics within the LV of the HF animals and hence sug-
gested a plausible explanation for the dyssynchronous LV
activation.
Materials and methods
Experimental tissue material
Ten male, sexually mature minipigs (35–40 kg) were
chronically instrumented in the laboratory of the Sector of
Medicine, Scuola Superiore Sant’Anna, Pisa, Italy. HF was
induced by pacing the LV anterior wall at 180 beats/min
for 3 weeks. Pigs were considered to develop severe HF
when the LV end-diastolic pressure was C20 mmHg and
the ejection fraction was \40%. Untreated animals were
used as healthy controls. Hemodynamic measurements,
MRI and PET examinations were performed in controls
and in HF animals and identiﬁed regional wall motion
abnormalities as reported earlier [23]. The minipigs were
then killed and their hearts were removed, dissected, and
immediately frozen in liquid nitrogen. The anterolateral
Table 1 Descriptive values for the distribution histograms of the ﬂow cytometric experiments
[log(P-TnI/TnI)]
distribution
Control pacing
site (n = 6)
Control opposite
site (n = 6)
HF pacing
site (n = 6)
HF opposite
site (n = 6)
25% percentile -0.45 -0.46 -0.65 -0.57
Median -0.27 -0.26 -0.37 -0.36
75% percentile -0.09 -0.09 -0.12 -0.15
IQR 0.36 0.37 0.53
?,# 0.42
Mean -0.28 -0.29 -0.41* -0.38
Std. deviation 0.29 0.31 0.43 0.35
Std. error of mean 0.002 0.002 0.003 0.002
Rows in italics were not analyzed statistically since these parameters cannot be interpreted at the single-particle level
* P = 0.0071 HF pacing versus control pacing site
? P = 0.0093 HF pacing versus control pacing site
# P = 0.0047 HF pacing versus HF opposite site
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123wall (pacing site) and inferoseptal region (opposite site) of
the LVs were separated. Transfer of the cardiac samples
between laboratories was performed on dry ice. The pigs
were treated and housed in accordance with the Italian
national guidelines (No. DLGS 27/01/1992, No. 116).
Immunohistochemistry
Porcine heart samples were sectioned in a cryostat at -20C
to obtain 10-lm-thick slices. All subsequent steps were
performed at room temperature. Slides were ﬁxed with ice-
cold acetone for 5 min and incubated in methanol for
20 min. The ﬁxed slides were then rinsed in PBS (con-
taining 150.7 mM NaCl, 3.22 mM KCl, 0.735 mM
KH2PO4, 8.6 mM Na2HPO4; pH 7.4) and blocked for
20 min in normal goat serum. A monoclonal mouse anti-
TnI primary antibody (Clone 19C7, Research Diagnostics
Inc., Flanders, USA; 1:500 dilution in PBS-BSA) was used
to analyze TnI independently of its phosphorylation status,
and a polyclonal rabbit anti-TnI (phospho S22 ? S23)
(Abcam, Cambridge, UK; 1:500 dilution in PBS-BSA) was
employed to assess PKA-mediated TnI phosphorylation
(P-TnI). Slides were incubated overnight at ?4C, followed
by a 30-min incubation at room temperature with anti-
mouse-Cy3 (red) and anti-rabbit-Cy2 (green) antibodies
(Jackson Laboratories, Bar Harbor, ME, USA; 1:200 dilution
in PBS) to visualize cardiac TnI and its PKA-speciﬁc phos-
phorylated form. To assess protein kinase C (PKC)-mediated
TnI phosphorylation, polyclonal rabbit anti-TnI primary
antibody (phospho T143) (Abcam, Cambridge, UK; 1:100
dilution in PBS-BSA) was used, followed by overnight
incubation at ?4C, then 30 min incubation at room
temperature with anti-rabbit-Biotin antibody (Jackson
Laboratories, Bar Harbor, ME, USA; dilution: 1:200).
Streptavidin-Cy2 (green) was used to visualize PKC-spe-
ciﬁc phosphorylation of TnI. Microscope slides were
mounted with Vectashield mounting medium containing
40,6-diamidino-2-phenylindole (DAPI) (Vector Laborato-
ries, Burlingame, CA, USA). Microscopic images of tissue
cuts were recorded with a NIKON Eclipse 80i Fluorescein
microscope, using a NIKON 109 objective (NA:0.30) at
1009 magniﬁcation. High-quality images were recorded
with an Olympus FluoView 1000 Confocal microscope,
using an Olympus LUCPLFLN 209 objective (NA:0.45)
and digital zoom at 1809 and 5409 magniﬁcations.
Back-phosphorylation of TnI
A back-phosphorylation assay was performed to assess the
phosphorylation level of TnI in protein homogenates of
permeabilized cardiomyocytes [11]. Permeabilized cardio-
myocytes were prepared as described elsewhere [8]. Reac-
tion mixtures contained 40 ll of the isolated cardiomyocyte
fraction {protein concentration 0.5 mg/ml in a modiﬁed
isolation solution [in mM: KCl 100, ethylene glycol tetra-
acetic acid (EGTA) 2, MgCl2 1, ATP 0.1, and imidazole
100; pH 7.0; all chemicals from Sigma-Aldrich, St. Louis,
MO, USA]}, 10 ll of modiﬁed isolation solution containing
32P-labeled ATP (ﬁnal speciﬁc activity: 1,500 cpm/pmol),
and 1 ll of PKA [from Sigma, St. Louis, MO, USA,
4,000 U/ml in 6 mg/ml of (dithiothreitol) DTT-containing
modiﬁed isolation solution]. The reaction was performed at
room temperature for 15 min. At the end, 50 ll of sodium
dodecyl sulfate (SDS) sample buffer (Sigma-Aldrich,
St. Louis, MO, USA) was added and the samples were boiled
for 5 min. Thirty microliters of boiled samples was loaded
onto 10% polyacrylamide gels, separated, and transferred
onto nitrocellulose membranes. Phosphate incorporation
into TnI was detected by autoradiography (blue-sensitive
RTGB ﬁlms from Primax, Berlin, Germany). Band inten-
sities (reﬂecting phosphate incorporation) were determined
by densitometry using Image J software (freeware from
http://www.nih.gov). Optical densities are shown in arbi-
trary units in the Figures.
Western immunoblotting
Porcine LV tissue samples were homogenized in radioim-
mune precipitation assay buffer containing Tris–Cl
50 mM, NaCl 150 mM, 1% Triton X-100, 0.1% SDS, and
1% sodiumdeoxycholate; pH 7.4. Protein concentrations
were determined by BCA assay (Sigma-Aldrich, St. Louis,
MO, USA) using bovine serum albumin (BSA) as standard,
and the concentration of each homogenate was adjusted to
4 mg/ml. The homogenates were then mixed with an equal
volume of 29 SDS sample buffer (Sigma-Aldrich,
St. Louis, MO, USA) and were boiled for 10 min before
electrophoresis. 50 lg of proteins was loaded onto 10%
SDS-polyacrylamide gels and, after separation, transferred
to nitrocellulose membranes. The membranes were probed
with antibodies against TnI (Clone 19C7, Research Diag-
nostics Inc., Flanders, NJ, USA, dilution: 1:5,000) and the
signal was detected with a peroxidase-conjugated anti-
rabbit IgG-speciﬁc antibody (Sigma-Aldrich, St. Louis,
MO, USA; dilution: 1:50,000). The bands were visualized
by enhanced chemiluminescence and evaluated with Image
J software. Only bands on the same membrane were used to
avoid alterations due to differences in transfer efﬁciency or
other technical reasons.
Flow cytometry
LV tissue samples (*0.04 g wet weight) were mechani-
cally disrupted and isolated as described earlier. In brief,
the isolated cells were permeabilized in cell isolation
solution (in mM: MgCl2 1, KCl 100, EGTA 2, ATP 4, and
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123imidazole 10; pH 7.0; all chemicals from Sigma-Aldrich,
St. Louis, MO, USA) as described elsewhere [29]. There-
after, the myocytes were incubated on ice for 90 min in
100 ll of isolation solution containing 2 mg/ml BSA
(Sigma-Aldrich, St. Louis, MO, USA) and primary anti-
body. Monoclonal mouse anti-TnI antibody (Clone 19C7,
Research Diagnostics Inc., Flanders, NJ, USA; dilution:
1:200), and a phosphorylation-sensitive polyclonal rabbit
anti-TnI antibody (phospho S22 ? S23) (Abcam, Cam-
bridge, UK; 1:100 dilution) were used as primary anti-
bodies, followed by a 30-min incubation on ice with
anti-mouse-Cy3 and anti-rabbit-Cy5 antibodies (Jackson
Laboratories, Bar Harbor, ME, USA; dilution: 1:50) to
label cardiac TnI and P-TnI. Myocytes were ﬁxed with ice-
cold 2% formaldehyde solution (in cell isolation solution)
for 30 min. All washing steps were performed with isola-
tion solution. The cell suspensions were gently sonicated
and then ﬁltered through a 50-lm-wide cell ﬁlter. Flow
cytometric experiments were carried out on a FACSArray
ﬂow cytometer (Becton–Dickinson, San Jose, CA, USA).
Fluorescence intensities for single particles were deter-
mined in six animals per group. 6,000–10,000 particles
were measured per animal. Cy3 ﬂuorescence was excited at
532 nm and detected at 585 ± 21 nm, whereas Cy5 was
excited at 635 nm and detected at 661 ± 8 nm. Cell debris
was excluded from the analysis by gating on the forward
and right angle light scatter signals. List mode ﬁles were
analyzed with the software REFLEX [39].
Force measurements in permeabilized cardiomyocyte
preparations
The force at saturating [Ca
2?]( Fo), the passive force
component (Fpassive), the Ca
2? sensitivity of isometric
force production (pCa50), the steepness of the Ca
2?–force
relationship (nHill), and the rate constant of force redevel-
opment at saturating Ca
2? levels (ktr,max; speciﬁc for the
maximal turnover rate of the actin-myosin cross-bridge
cycle) were used as parameters of the myoﬁbrillar function.
Moreover, these mechanical data were determined at sar-
comere lengths (SLs) of 1.9 and 2.3 lm to test for possible
alterations in length-dependent Ca
2? sensitization, i.e. in
the molecular background of the Frank-Starling mecha-
nism. The pCa, i.e. -log[Ca
2?], values of the relaxing
solution and the activating solution used during the force
measurements (pH 7.2) were 9.0 and 4.75, respectively.
The composition of the relaxing solution differed from that
of the activating solution only in the use of 7 mM EGTA
instead of Ca-EGTA. Both solutions were supplemented
with protease inhibitors: 0.5 mM phenylmethylsulfonyl
ﬂuoride (PMSF) (Sigma-Aldrich, St. Louis, MO, USA),
40 lM leupeptin (Sigma-Aldrich, St. Louis, MO, USA),
and 10 lM E-64 (Sigma-Aldrich, St. Louis, MO, USA).
The technique employed for force measurements in a
single myocyte-sized preparation was detailed earlier [29].
Brieﬂy, a single permeabilized cardiomyocyte was attached
to a mechanical measuring system. After precise SL
adjustment to 2.3 lm, isometric Ca
2? contractures were
evokedat15Cduringrepeatedactivation–relaxationcycles
by moving the myocyte from Ca
2?-free relaxing solution to
activating solutions of gradually increasing [Ca
2?]. Iso-
metric force values were normalized for maximal Ca
2?-
activatedactiveforce,andCa
2?–forcerelationswereplotted
and ﬁtted with a modiﬁed Hill function to determine the
Ca
2? sensitivity of isometric force production, i.e. pCa50,
and the cooperativity within the contractile machinery
(nHill).Ca
2?–forcerelationshipsweredeterminedbeforeand
after in vitro PKA exposures. The PKA stock solution
contained the catalytic subunit of PKA from bovine heart
[100 U in distilled water supplemented with 6 mg/ml of
DTT at a protein concentration of 0.05 mg/ml, as recom-
mended by the manufacturer (Sigma-Aldrich, St. Louis,
MO, USA; Catalog number: P2645; LOT number:
021M7676V)]. To assess the effects of PKA, cardiomyo-
cytes were incubated for 20 min in 100 ll of relaxing
solution supplemented with 5 ll of the PKA stock solution.
In a separate study, isometric force measurements were
performedﬁrstataSLof1.9 lmandthenataSLof2.3 lm.
During single Ca
2? contractures, once the peak force
was reached, the rate constant of force redevelopment
(ktr,max) was determined by a quick release–restretch
maneuver in the activating solution. As a result of this
intervention, the force dropped from peak level to zero,
allowing determination of the total force level (Ftotal), and
then started to redevelop. The cardiomyocyte was next
returned to the relaxing solution, where a shortening to
80% of the original preparation length was performed to
assess the passive force level (Fpassive). The active iso-
metric force (Fo) was calculated by subtracting the passive
force from the total isometric force. Fo and Fpassive were
normalized for the cardiomyocyte cross-sectional area,
calculated from the width and thickness of the myocyte,
which were measured with optically directed light.
Data analysis, statistics
Ca
2?–force relations were ﬁtted to a modiﬁed Hill
equation:
F ¼ Fo Ca2þ  nHill= Ca
nHill
50 þ Ca2þ  nHill 
where F is the steady-state force at a given [Ca
2?], while
Fo, nHill and Ca50 (or pCa50) denote the maximal Ca
2?-
activated force at saturating [Ca
2?], and the slope and
midpoint of the sigmoidal relationship, respectively.
The force redevelopment after the release–restretch
maneuver was ﬁtted to a single exponential function in
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123order to estimate the rate constant of force redevelopment
(ktr,max) at the maximal [Ca
2?] level:
Ft ðÞ¼Fi þ Fa 1   e ktr;maxt 
where F(t) is the force at any time (t) after the restretch at
the maximal [Ca
2?], and Fi and Fa denote the initial force
after the restretch and the amplitude of Ca
2?-activated
force redevelopment, respectively. Each experimental
preparation was ﬁtted individually, the ﬁtted parameters
were pooled, and the mean values are reported.
Statistical analyses of the back-phosphorylation assay
and mechanical measurements were performed by
ANOVA followed by a Bonferroni test for multiple com-
parisons between groups. Relationships between two con-
tinuous variables were assessed with linear regression
analysis. Differences due to PKA treatment during
mechanical measurements were analyzed using a paired
Student’s t test. Statistical signiﬁcance was accepted at
P\0.05. Analysis of the thousands of single data points
obtained from the ﬂow cytometric measurements required
a modeling method that does not assume independence
across single particles, but is able to handle the correlation
between particle-level measurements within the same ani-
mal’s heart. Thus, conventional ANOVA or linear regres-
sion could not be used, but maximum likelihood mixed
effects multilevel modeling with interaction between
groups and sites was found to be appropriate. Estimation of
the pacing effect was based on mean log relative signal
intensities [log(P-TnI/TnI)] for the level of phosphorylation
and on interquartile ranges (IQRs) for the heterogeneity of
phosphorylation. Logarithmic transformation of the data
improved the normality of the distribution of the variables.
Results
To test homogeneity in PKA-mediated myoﬁlament pro-
tein phosphorylation, the level of TnI phosphorylation was
visualized during immunohistochemical studies on myo-
cardial tissue samples in the anterior/anterolateral (pacing
site) and in the inferoseptal regions (opposite site) in HF
and control hearts. Myocardial tissue samples were labeled
with speciﬁc antibodies against TnI, the phosphorylated
form of TnI (P-TnI) at PKA-speciﬁc sites (S22 ? S23),
and slides were also mounted with DAPI-containing
medium. In Fig. 1, beside the three separate signals cap-
tured with ﬂuorescent light microscopy, merged pictures
from each group are also shown. In general, the staining of
tissue slices for P-TnI resulted in a more homogeneous
staining intensity in the controls and opposite site of HF
hearts than in the pacing site of HF hearts, where areas with
various P-TnI intensity levels could be observed. Areas
with given staining intensities were formed by clusters of
cardiomyocytes with similar P-TnI signal levels in the
pacing site of HF hearts (Fig. 1b). The P-TnI staining did
not appear to vary within single cardiomyocytes. The
homogenous picture with phosphorylation-insensitive TnI
antibody and the identiﬁcation of cardiomyocyte nuclei by
DAPI were in contrast with the inhomogeneous pattern
observed following P-TnI staining in the same myocardial
sections, and hence indicated that ﬁbrosis or necrosis could
not explain the heterogeneous staining pattern at the pacing
sites of HF hearts. In a separate study, we also attempted to
test the homogeneity of PKC-mediated TnI phosphoryla-
tion at the pacing site of HF animals. To this end, myo-
cardial tissue samples were labeled similarly as those in
Fig. 1 for the PKA-speciﬁc TnI phosphorylation sites and
also with antibodies speciﬁc for a PKC-speciﬁc TnI
phosphorylation site (T143) (Online Resource 1). In gen-
eral, these sections suggested TnI phosphorylation to be
more homogenous at the PKC site than at the PKA-speciﬁc
sites.
The mean levels of myoﬁlament protein phosphorylation
were tested in a back-phosphorylation assay. The mean
phospho-speciﬁc TnI signal intensity of protein homoge-
nates of permeabilized cardiomyocytes from the pacing
sites of the HF animals (58 ± 14.49 AU) was signiﬁcantly
higher than that in the control pigs (5.41 ± 1.34 AU;
P\0.05), which was suggestive of a PKA-dependent
phosphorylation deﬁcit of TnI at the HF pacing site (Fig. 2a,
b). The phosphorylation-dependent intensities at the
molecular masses of 20 and 150 kDa [i.e. close to those of
MyBP-C and myosin light chain 2 (MLC2)] correlated with
TnI phosphorylation (Fig. 2c). Parallel changes in TnI
phosphorylation and MyBP-C phosphorylation are expec-
ted upon PKA applications; however, phosphate incorpo-
ration into MLC2 is not expected for PKA exposures, and
hence the protein at 20 kDa could be a protein other than
MLC2. The difference in the overall phosphorylation level
of myocardial TnI (P-TnI) between the pacing and the
opposite sites of the HF pigs did not reach signiﬁcance
(P[0.05) (HF opposite site: 40.3 ± 9.86 AU) (Fig. 2a, b).
Motivated by the results of our histochemical observa-
tions and back-phosphorylation assays, we developed a
protocol that allowed the quantitative evaluation of regio-
nal differences in the level of TnI phosphorylation in sus-
pensions of permeabilized cardiomyocytes by ﬂow
cytometry. This method yielded relative P-TnI levels in a
vast number of cardiomyocytes following dual-labeling of
cardiomyocytes for TnI and P-TnI (Fig. 3a). Distribution
histograms of logarithmically transformed relative signal
intensities [log(P-TnI/TnI)] were then expressed for the
two regions of interest in the HF and control groups by
pooling data from six hearts in each group. Figure 3b
shows that the distribution histogram of the pacing site in
the controls demonstrated close to Gaussian distribution, in
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123contrast with the histogram of the HF pacing site, which
appeared to be asymmetrical due to an increase in car-
diomyocyte count at relatively low [log(P-TnI/TnI)] ratios.
In agreement with the results of our back-phosphorylation
assays (Fig. 2a, b), the mean value of [log(P-TnI/TnI)] at
the HF pacing site was signiﬁcantly lower than that at the
Fig. 1 Immunohistochemistry.
a Myocardial tissue samples
were labeled with speciﬁc
antibodies against TnI, the
phosphorylated form of TnI
(P-TnI) and nuclei with DAPI.
Disparate amounts of P-TnI
intensities resulted in variable
yellow intensities on the merged
picture of the HF pacing group.
b Capturing images of P-TnI
stained slices under a confocal
microscope revealed cell-to-cell
differences: clusters of
cardiomyocytes with divergent
levels of TnI phosphorylation
could be distinguished in the HF
animals at the pacing site
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123same site in the control animals (-0.41 vs. -0.28 for the
HF pacing site and the control pacing site, respectively;
P = 0.0071), and hence both of these assays pointed to a
relative reduction in P-TnI in the paced region of failing
hearts. Moreover, the IQR in this group was signiﬁcantly
higher than that at the pacing site of the controls or at the
opposite site of failing hearts (0.53 vs. 0.36 or 0.42, for the
HF pacing, control pacing and HF opposite sites, respec-
tively; P = 0.0093 vs. control pacing site; P = 0.0047 vs.
HF opposite site). The widening of the IQR at the HF
pacing site reﬂected the increased scatter in the levels of
relative TnI phosphorylation at the pacing site among the
cardiomyocytes of failing hearts. Descriptive values of
distribution histograms are given in Table 1.
Mean levels of log(P-TnI/TnI) intensities with 95%
conﬁdence intervals for each animal are illustrated in
Fig. 4. This representation allowed us to analyze the vari-
ability of TnI phosphorylation in the different regions of
interest in the individual control and failing hearts. In
general, the log(P-TnI/TnI) values for the control hearts
were scattered in a narrower range than those for the failing
hearts. Further, in the control animals the means of
log(P-TnI/TnI) were randomly higher or lower for the
pacing or opposite sites, and the differences between these
two sites (with the exception of control 4) were small. In
contrast, in HF (with the exception of HF 6) the means for
the log(P-TnI/TnI) values at the pacing sites were lower than
those at the opposite sites. Moreover, the differences
between the two sites of individual failing hearts were about
twice the mean difference detected within the control group.
A hypothetical difference in cardiomyocyte mechanics
was also studied by means of direct force measurements on
single permeabilized cardiomyocytes isolated from HF and
control animals (Fig. 5). Ca
2? sensitivity curves of iso-
metric force production (Ca
2?–force relations) were deter-
mined for individual cardiomyocytes and subsequently
averaged in all groups at 2.3 lm SL before and after PKA
exposures (Fig. 5a–d). Force values at intermediate [Ca
2?]
were normalized to maximal Ca
2?-activated force (Fo) and
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Fig. 2 TnI back-phosphorylation. a Results of autoradiography (top)
and western immunoblotting (bottom) in a representative TnI back-
phosphorylation assay.
32P-labeled ATP was used to determine PKA-
dependent phosphate incorporation into TnI at the pacing and
opposite LV sites in control and HF animals following SDS gel
electrophoresis. Signal intensities in the autoradiograms were con-
sidered to be directly proportional to the extents of inorganic
phosphate (Pi) incorporation into TnI in the presence of PKA
(? signs) in vitro, and inversely proportional to the initial levels of
phosphorylation of TnI prior to PKA application in vivo. Signal
intensities in the absence of PKA were negligible (- signs). Western
immunoblots developed with a TnI-sensitive antibody conﬁrmed
comparable protein loads during all tests. b Statistical analysis on the
results of back-phosphorylation assays under identical conditions
suggested a lower mean level of TnI phosphorylation for the HF
pacing site than for the control pacing site (columns show
means ± SEM; n number of animals, AU optical density in arbitrary
units, *P\0.05 HF pacing vs. control pacing site). c Correlations
between TnI phosphorylation and additional proteins at 20 and
150 kDa. Signal intensities at 20 and 150 kDa from pacing and
opposite sites of individual animals were plotted in an X–Y diagram as
functions of Pi incorporation into TnI in the respective samples. Lines
represent relationships between phosphorylation at 20 or 150 kDa and
TnI phosphorylation from linear regression analyses, suggesting
positive correlations between these variables (r = 0.71, P\0.0001;
r = 0.74, P\0.0001, respectively)
c
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123plotted as a function of pCa. A Hill function was then used
to determine pCa50, which therefore illustrated the Ca
2?
sensitivity of force production. Mean pCa50 values of con-
trol hearts at the pacing site did not differ signiﬁcantly
from those of the opposite site in control and HF hearts
before PKA treatments (5.77 ± 0.01, 5.75 ± 0.01 and
5.73 ± 0.03, respectively). However, mean pCa50 (and
hence Ca
2? sensitivity of force production) was signiﬁ-
cantly higher at the pacing site of HF hearts (5.86 ± 0.03)
than at all the other sites of HF and control hearts. More-
over, PKA exposures reduced pCa50 by the largest degree in
cardiomyocytes of the pacing site of HF animals, thereby
eliminating the differences in the Ca
2? sensitivities of force
production among the four groups of cardiomyocytes. In
addition, the distributions of pCa50 at the pacing sites of the
failing and the control hearts resembled the characteristics
of those obtained in our ﬂow cytometric assays and were
therefore also in agreement with the biochemical and his-
tochemical ﬁndings (Fig. 5e–h). Furthermore, in vitro PKA
treatments evoked a wider range in Ca
2? sensitivity
reductions at the HF pacing site than at all other sites. Mean
values of Fo, Fpassive and the cross-bridge-sensitive ktr,max
are given in Table 2. Fpassive at the HF pacing site was
signiﬁcantly higher than at the HF opposite site; however,
no signiﬁcant differences in Fo and in maximal actin-
myosin cross-bridge cycle rates (ktr,max) were found
between the different experimental groups.
In a separate study, the length dependencies of the
mechanical parameters were investigated by performing
force measurements at the SL of 1.9 lm and subsequently
Fig. 3 Flow cytometry.
a Microscopic images of a
representative permeabilized
cardiomyocyte (top panel) dual-
labeled for TnI (red) and P-TnI
(green) for ﬂow cytometric
evaluation. Signal intensities
were plotted in X–Y diagrams,
where the values on the X and
Y axes reﬂected TnI and P-TnI
intensity levels, respectively
(middle and lower panels,
n & 20,000 cardiomyocytes
from 6 hearts). The wider
scatter of the data obtained from
the HF pacing site (bottom
panel) than those from the
control pacing site (middle
panel) suggested more
heterogeneous TnI
phosphorylation levels in the
cardiomyocytes of the HF
animals in the paced area.
b Distribution of relative TnI
phosphorylation in isolated
cardiomyocytes. Distribution
proﬁles of logarithmically
transformed relative signal
intensities [log(P-TnI/TnI)]
were expressed for the four
groups. (The IQRs between the
25 and 75 percentile values of
the distribution histograms are
highlighted; n number of
animals; *P = 0.0071 HF
pacing vs. control pacing site;
?P = 0.0093 HF pacing vs.
control pacing site;
#P = 0.0047 HF pacing vs. HF
opposite site)
Page 8 of 13 Basic Res Cardiol (2012) 107:244
123at the SL of 2.3 lm. In short, length dependencies of Fo,
Fpassive, and the Ca
2? sensitivity of force production were
observed in all groups of cardiomyocytes, implying that the
stretch-dependent mechanical characteristics of the
cardiomyocytes are well preserved during the development
of pacing-induced HF (data not shown).
Discussion
The results of this study have revealed a non-uniform down-
regulation of myocardial PKA-dependent TnI phosphoryla-
tion in a porcine model of pacing-induced HF. Interestingly,
the cell-to-cell variability in the level of P-TnI was larger in
thevicinityofthepacingelectrodethaninnon-pacedregions
oftheLV.Consequently,weproposethattheinhomogeneity
in PKA-dependent contractile protein hypophosphorylation
maycontributetotheregionalmechanicaldysfunctionofthe
remodeled myocardium in this model of HF.
Dyssynchrony in ventricular contractile responses is
considered to be a major contributor of the mechanical
dysfunction in the remodeled LV, and hence electrical
resynchronization offers beneﬁt for HF patients with a
signiﬁcant QRS prolongation [32]. Regional myocardial
differences have repeatedly been noted in various models
of HF induced by electrical stimulation [10, 14, 23, 25, 38].
In open-chest anesthetized dogs, abnormal wall motion at
the target site of the LV yielded early shortening and late
systolic lengthening, whereas the shortening pattern at the
remote site remained unaffected [14]. Various mechanisms
have been postulated to explain these region-speciﬁc
changes, ranging from matrix metalloproteinase-9 activa-
tion [14] to transmural and trans-chamber expression gra-
dients of proteins such as phosphorylated ERK mitogen-
activated protein kinase, sarcoplasmic reticulum Ca
2?-
ATPase, phospholamban, or gap junction protein connexin
43 [20, 38]. Paracrine/autocrine signaling mechanisms
have also been stressed as players in the development of
regional tissue alterations in pacing-induced HF. For
instance, the cardiotropin-1 expression was found to be
preferably increased in the vicinity of the pacemaker [31].
In a canine model of pacing-induced HF, an orchestrated
shift in the pattern of expression of respiratory chain sub-
units, mitochondrial bioenergetic enzymes, and apoptotic
proteins with distinct differences in the regional distribu-
tion and in the subpopulations of mitochondria have been
described [25]. Collectively, it is currently not entirely
clear which signaling processes are primarily involved in
regional mechanical alterations and how they are linked
with potential changes in the Ca
2? responsiveness of the
myoﬁlaments and/or with the Ca
2? handling of cardio-
myocytes [1, 2, 17]. Nevertheless, it is tempting to spec-
ulate that paracrine responses to natriuretic peptides may
relate to interactions between cGMP and cAMP-dependent
intracellular signaling [13].
In view of the central position of the b-adrenergic cas-
cade in the regulation of myocardial contractility, several
previous investigations addressed its hypothetical involve-
ment in the regional characteristics of pacing-induced HF.
Indeed, the efferent sympathetic function and b-adrenergic
responsiveness appeared to be reduced in association with
the development of pacing-induced HF in dogs with region-
speciﬁc alterations in function [19, 36], although the bio-
chemical and cellular parameters of b-adrenergic signaling
did not clearly exhibit regional characteristics [3, 18, 36,
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Table 2 Mean values of active, passive force and ktr,max obtained during direct force measurements in permeabilized cardiomyocytes
Control pacing
site (n = 23)
Control opposite
site (n = 20)
HF pacing
site (n = 21)
HF opposite
site (n = 29)
Fo (kN/m
2) 12.83 ± 1.73 15.47 ± 1.84 12.05 ± 1.15 16.81 ± 1.42
Fpassive (kN/m
2) 1.46 ± 0.20 1.69 ± 0.43 2.26 ± 0.48
* 1.17 ± 0.11
ktr,max (1/s) 0.81 ± 0.06 0.75 ± 0.04 0.82 ± 0.05 0.96 ± 0.05
Values are means ± SEM
n number of cardiomyocytes from 5 control and 8 HF hearts
* P\0.05 HF pacing versus HF opposite site
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12340]. At the cardiomyocyte level, a decrease in basal
b-adrenergic signaling would predict an increase in the
Ca
2? sensitivity of myoﬁbrillar force production, a change
often correlated with the coordinated hypophosphorylation
of TnI and MyBP-C [21, 24, 43]. Experimental data
obtained during an in situ assessment of myoﬁlament Ca
2?
responsiveness suggested either preserved or decreased
Ca
2? sensitivity of myoﬁbrillar force production in a canine
model of pacing-induced HF [16]. Moreover, in the porcine
model of pacing-induced HF, the relative increase in LV
contractility in response to low-dose dobutamine stimula-
tion was higher at the pacing site than at the opposite site,
although the basal contractility was lower at the pacing site
than at the opposite site [22].
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123In our present study, we focused not only on regional, but
also on intraregional aspects of a hypothetically blunted
PKA-mediated TnI phosphorylation, along with the devel-
opment of pacing-induced HF in pigs. We hypothesized that
tissue-level alterations in TnI phosphorylation driven by the
b-adrenergic system might be associated with regional
differences in the mechanical function of the remodeled
myocardium. Our back-phosphorylation assays revealed
signiﬁcantly decreased TnI phosphorylation at the pacing
site of the HF animals as compared with the controls,
consistently with a hypothetical down-regulation of the
b-adrenergic system at the pacing site of the HF animals and
hence implying an increase in the Ca
2? sensitivity of
myoﬁbrillar force production (pCa50). Accordingly, the
mean pCa50 values were signiﬁcantly higher at the HF
pacing site than at the opposite site or both sides in controls,
and this difference could be eliminated by in vitro PKA
treatments. In addition, immunohistochemistry, ﬂow
cytometry, and direct force measurements conﬁrmed a
relatively high cell-to-cell variability in the relative P-TnI
levels at the pacing site of the HF animals. The preservation
of most of the mechanical parameters in the cardiomyocytes
of the paced region of the HF animals (e.g. the SL depen-
dence of the Ca
2? sensitivity of force production, ktr,max,
etc.) suggested an unchanged Frank-Starling mechanism
and cross-bridge cycling rates in these cardiomyocytes.
Overall, our observations suggested that alterations in the
myoﬁlament function of the cardiomyocytes were mirrored
by pCa50 at the pacing site of the HF animals, a change that
can be correlated to PKA-dependent TnI and MyBP-C
phosphorylation. Therefore, we propose that dysregulation
of PKA-dependent contractile protein phosphorylation may
contribute to the regional contractile dysfunction observed
in the porcine model of pacing-induced HF [23]. Addi-
tionally, the increase in Fpassive at the pacing site due to
PKA-dependent hypophosphorylation of other myoﬁlament
proteins (e.g. titin) could participate in the increase in LV
end-diastolic pressure in these hearts (from *6t o* 20
mmHg) [7]. Nevertheless, our present investigations did not
clarify to which extent regional alterations in myoﬁlament
protein phosphorylation were involved in functional
hemodynamic alterations (e.g. reduction in the ejection
fraction from *76 to *35%) [23].
To the best of our knowledge, this is the ﬁrst analysis of
tissue-level inhomogeneities in cardiomyocyte TnI phos-
phorylation through a combination of a number of sensitive
methods (protein biochemistry, histochemistry, direct force
measurements and cell cytometry) during the development
of non-ischemic HF. A diminishing transmural gradient in
contractile protein phosphorylation has previously been
implicated in post-ischemic myocardial remodeling in rats
[9], although similar features have not been demonstrated
in dogs suffering from pacing-induced HF [20]. Our data
revealed that the level of TnI phosphorylation spans a
wider range in the vicinity of the pacing electrode than
elsewhere and suggested that it can be distinctly different
in clusters of cardiomyocytes during pacing-induced HF.
At present, we cannot provide an explanation for this dis-
tribution pattern of P-TnI staining intensity; we speculate
that it may be related to the physical characteristics of the
stimulating electrical current on the myocardium.
Overall, the rapid pacing of the LV induced the
remodeling of porcine hearts and led to HF, which could be
characterized by an overall decrease in PKA-mediated TnI
phosphorylation close to the site of electrical stimulation.
The level of PKA-dependent phosphorylation of TnI
exhibited a larger cell-to-cell variation in the paced region
of the LV than in more remote areas or in controls. This
intraregional inhomogeneity in this b-adrenergic-depen-
dent variable affects the Ca
2? sensitivity of myoﬁbrillar
force production and may thereby contribute to dyssyn-
chronous and hence impaired LV contractions in the por-
cine model of pacing-induced HF.
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Fig. 5 Mean Ca
2?–force relations and distributions of pCa50 values
in isolated cardiomyocytes. a Ca
2?–force relations of isolated
cardiomyocytes obtained from the pacing and opposite sites of the
HF animals before and after in vitro PKA treatments. The leftward
position of the Ca
2?–force relations at the HF pacing site before PKA
treatment illustrated an increased Ca
2?-sensitivity of force production
in cardiomyocytes of this region relative to all others. After PKA
treatment, a rightward shift in the Ca
2?–force relation was observed.
b Small differences between the Ca
2?–force relationships of the
control pacing and control opposite groups could be detected before
and after in vitro PKA treatment. c Means of pCa50 values in the four
groups of cardiomyocytes before and after in vitro PKA treatment.
Mean pCa50 at the HF pacing site was signiﬁcantly higher than in all
other groups under basal conditions, and this difference could be
eliminated by PKA (*P\0.05). d PKA-evoked changes in pCa50
values in the four experimental groups. The effect of PKA on mean
pCa50 was the highest at the pacing site of HF animals (*P\0.05).
The Hill coefﬁcient did not differ signiﬁcantly among the four
experimental groups before and after PKA exposures (nHill *2.6).
e–h Distributions of pCa50 values in cardiomyocytes from the four
experimental groups before and after in vitro PKA treatment. pCa50
values of the HF pacing group were dispersed on a wider range than
in all other groups. After PKA treatment, a narrower distribution for
the pCa50 values could be measured in HF cardiomyocytes at the
pacing site
b
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